Skip to content
healthcare.dev
Get a free key

INVOKAMET

NDC 50458-541, canagliflozin and metformin hydrochloride, tablet, film coated, from Janssen Pharmaceuticals, Inc..

Product NDC
50458-541
Status
Listed
Labeler
Janssen Pharmaceuticals, Inc.
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA204353
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50458-541 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CANAGLIFLOZIN50 mg/1
  • METFORMIN HYDROCHLORIDE1000 mg/1

Pharmacologic classes

Biguanide [EPC]; Biguanides [CS]; P-Glycoprotein Inhibitors [MoA]; Sodium-Glucose Cotransporter 2 Inhibitor [EPC]; Sodium-Glucose Transporter 2 Inhibitors [MoA]

Package NDCNDC-11Package
50458-541-605045805416060 TABLET, FILM COATED in 1 BOTTLE (50458-541-60)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/6868666b-c25e-40d1-9d1f-306bbe9390c1

  • NADAC price for package 50458054160

    GET /v1/drugs/nadac/50458054160

Use it

Look up 50458-541 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50458-541 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50458-541. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.